Doximity, Inc.
Financial highlights
| Metric | FY 03/31/26 | FY 03/31/25 | FY 03/31/24 | FY 03/31/23 | FY 03/31/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $644.9M | $570.4M | $475.4M | $419.1M | $343.5M |
| Cost of revenue | $70.3M | $55.9M | $50.7M | $53.5M | $39.8M |
| Gross profit | $574.5M | $514.5M | $424.8M | $365.6M | $303.8M |
| Research and development | $130.7M | $93.0M | $82.0M | $80.2M | $62.4M |
| Operating expenses | $359.6M | $286.7M | $260.9M | $240.5M | $190.2M |
| Operating income | $214.9M | $227.8M | $163.9M | $125.1M | $113.5M |
| Pretax income | $250.0M | $263.6M | $185.2M | $133.2M | $114.0M |
| Income tax expense | $54.0M | $40.4M | $37.6M | $20.3M | -$40.8M |
| Net income | $196.1M | $223.2M | $147.6M | $112.8M | $154.8M |
| Balance Sheet | |||||
| Cash and equivalents | $219.2M | $209.6M | $96.8M | $158.0M | $112.8M |
| Current assets | $944.3M | $1.1B | $912.9M | $975.5M | $904.1M |
| Total assets | $1.1B | $1.3B | $1.1B | $1.1B | $991.4M |
| Current liabilities | $155.0M | $156.3M | $147.2M | $139.5M | $111.3M |
| Total liabilities | $172.8M | $181.7M | $178.0M | $170.8M | $112.8M |
| Stockholders' equity | $950.8M | $1.1B | $901.4M | $966.1M | $878.6M |
| Cash Flow Statement | |||||
| Cash from operations | $326.5M | $273.3M | $184.1M | $179.6M | $126.6M |
| Depreciation and amortization | $14.4M | $10.7M | $10.3M | $10.3M | $5.0M |
| Stock-based compensation | $121.6M | $72.4M | $51.1M | $47.8M | $31.4M |
| Capital expenditure | $0 | $0 | $147,000 | $1.7M | $1.9M |
| Free cash flow | $326.5M | $273.3M | $183.9M | $177.9M | $124.7M |
| Share repurchases | $431.7M | $120.3M | $280.7M | $85.3M | $2.7M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 184.7M · Free float 3.8%
Annual filing data through FY ended March 31, 2026; float as of July 4, 2026.